Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
Respiratory Endoscopy Center of Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
Faculty of Medicine, Cairo University, Cairo, Egypt
King Saud Hospital, Unaizah, Qassim, Saudi Arabia
Assiut University, Assiut, Egypt
Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
Odense University Hospital, Odense C, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.